Market Place
Sourcing Support
AstraZeneca Pharma to launch COPD drug in Jan 2025; stock up 3%
19 Nov 2024 //
BUSINESS STD
AstraZeneca Pharma gains on plan to launch COPD drug
19 Nov 2024 //
BUSINESS STD
Lunit Collaborates with AstraZeneca on AI Pathology Tools
18 Nov 2024 //
PR NEWSWIRE
AstraZeneca India, Academy of Paediatrics Raise RSV Awareness
14 Nov 2024 //
EXPRESSPHARMA
AstraZeneca Pharma India Q2FY25 net profit falls 27% to Rs 38 cr
14 Nov 2024 //
BUSINESS STANDARD
AZ tacks on $2B to its investment in US manufacturing, R&D
13 Nov 2024 //
FIERCE PHARMA
AstraZeneca says China head has lawyer, but company still in dark
13 Nov 2024 //
REUTERS
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat
12 Nov 2024 //
REUTERS
Merck, AstraZeneca Announce Phase 3 Win for Cancer Drug
12 Nov 2024 //
FIERCE BIOTECH
Koselugo Shows Improve in NF1 Plexiform Neurofibromas in Ph 3 Trial
12 Nov 2024 //
BUSINESSWIRE
AstraZeneca’s 9M and Q3 2024 results
12 Nov 2024 //
BUSINESSWIRE
Amgen, AZ`s Tezspire excels in phase 3 rhinosinusitis trial
09 Nov 2024 //
FIERCE PHARMA
Enhertu Wins 2024 Prix Galien USA Best Biotech Product
08 Nov 2024 //
BUSINESSWIRE
Monopar Therapeutic Report Q3 2024 Financial Results & Developments
08 Nov 2024 //
GLOBENEWSWIRE
AstraZeneca Opens New ADC Manufacturing Facility in Singapore
07 Nov 2024 //
BIOSPECTRUM
AstraZeneca Showcases Hematology Portfolio & Pipeline at ASH 2024
07 Nov 2024 //
BUSINESSWIRE
AstraZeneca`s China chief in custody, believes unrelated to insurance probe
07 Nov 2024 //
REUTERS
AstraZeneca stock tanks over fears of expanding China probe
06 Nov 2024 //
FIERCE PHARMA
AstraZeneca shares fall on report of potential China probe fallout
05 Nov 2024 //
REUTERS
AstraZeneca says experimental obesity pill safe in early-stage trial
05 Nov 2024 //
REUTERS
Cellectis Reports Q3 2024 Business Updates and Results
04 Nov 2024 //
GLOBENEWSWIRE
AstraZeneca still `playing to win` in obesity, execs say
04 Nov 2024 //
FIERCE BIOTECH
AstraZeneca backs campaign to improve lives of COPD patients
04 Nov 2024 //
FIERCE PHARMA
AstraZeneca`s Byetta Receives Approval in US
01 Nov 2024 //
FDA
AstraZeneca`s China president faces `ongoing investigation`
30 Oct 2024 //
FIERCE PHARMA
Datopotamab Deruxtecan-Based Trials Start in Advanced NSCLC
30 Oct 2024 //
BUSINESSWIRE
Fasenra approved in the EU for eosinophilic granulomatosis (EGPA)
29 Oct 2024 //
PRESS RELEASE
BeiGene, ex-AstraZeneca exec faces investigation in China: reports
25 Oct 2024 //
FIERCE PHARMA
AZ licenses discarded rare disease drug to Monopar Therapeutics
25 Oct 2024 //
FIERCE BIOTECH
DoP Rejects Review Applications on Metoprolol Pricing
24 Oct 2024 //
PHARMABIZ
Eccogene Receives $60M Milestone Payment from AstraZeneca
23 Oct 2024 //
GLOBENEWSWIRE
AstraZeneca`s new TV spot for COPD drug Breztri sets sail
22 Oct 2024 //
FIERCE PHARMA
Wainzua Recommended For EU Approval For Hereditary Amyloidosis
21 Oct 2024 //
PR NEWSWIRE
AstraZeneca Advances Infectious Disease Protection Science At IDWeek
18 Oct 2024 //
INDPHARMAPOST
breast cancer pill could enter $12 bln market if trials succeed
09 Oct 2024 //
REUTERS
AZ pads data package for Airsupra in patients with milder asthma
09 Oct 2024 //
FIERCE PHARMA
AstraZeneca Puts $2B On The Line for Preclinical Heart Disease Drug
08 Oct 2024 //
BIOSPACE
AstraZeneca`s vision for the future of respiratory care
07 Oct 2024 //
FIERCE PHARMA
Thermo Fisher`s Infant making RSV Drug Plant Breached FDA Rules
05 Oct 2024 //
REUTERS
BMS` Opdivo joins lung cancer treatment ring with key FDA approval
04 Oct 2024 //
FIERCE PHARMA
CALQUENCE® Gets US Priority Review For Mantle Cell Lymphoma
03 Oct 2024 //
BUSINESSWIRE
Owkin And AstraZeneca Partner On AI Breast Cancer Screening
02 Oct 2024 //
BUSINESSWIRE
Arcus To Test Casdatifan-Volrustomig Combo In Renal Cancer
02 Oct 2024 //
BUSINESSWIRE
ENHERTU® Gets Priority Review For HER2-Low Breast Cancer
01 Oct 2024 //
BUSINESSWIRE
ENHERTU Granted Priority Review For HER2 Low Breast Cancer
30 Sep 2024 //
BUSINESSWIRE
FDA expands label for AZ`s Tagrisso in NSCLC indication
27 Sep 2024 //
FIERCE PHARMA
AstraZeneca extends AI immuno-oncology R&D pact with Immunai
26 Sep 2024 //
FIERCE BIOTECH
TAGRISSO Approved For Stage III EGFR-Mutated Lung Cancer
26 Sep 2024 //
BUSINESSWIRE
Datopotamab Deruxtecan Results In TROPION-Breast01 Trial
23 Sep 2024 //
BUSINESSWIRE
Datopotamab Deruxtecan Final OS Results In Breast Cancer Trial
23 Sep 2024 //
BUSINESSWIRE
AstraZeneca Pharma India to launch Tremelimumab
23 Sep 2024 //
INDIANPHARMAPOST
AstraZeneca`s drug disappoints in breast cancer survival trial
23 Sep 2024 //
REUTERS
US FDA approves AstraZeneca`s self-administered nasal spray
21 Sep 2024 //
REUTERS
AIM ImmunoTech Reports Positive Data In Pancreatic Cancer Study
19 Sep 2024 //
GLOBENEWSWIRE
Daiichi, AZ Launch Enhertu DTC Campaign
19 Sep 2024 //
FIERCE PHARMA
AstraZeneca to launch Palivizumab (Synagis) in India
19 Sep 2024 //
EXPRESSPHARMA
AstraZeneca`s Fasenra Approved in the US for Rare Blood Vessel Disease
19 Sep 2024 //
CONTRACTPHARMA
Lupus landscape `poised for evolution` as US doctors eagerly await new entrants
18 Sep 2024 //
FIERCE PHARMA
AstraZeneca`s Imfinzi extends life in bladder cancer type
17 Sep 2024 //
FIERCE PHARMA
Imfinzi Plus Imjudo Shows 5-Year Survival In Liver Cancer
16 Sep 2024 //
BUSINESSWIRE
